首页|microRNA在深静脉血栓形成领域中的研究进展

microRNA在深静脉血栓形成领域中的研究进展

扫码查看
miRNA是一类内源性RNA分子,长度通常为19~25 个核苷酸,通过识别同源序列并介入转录、翻译或表观遗传过程,来调节基因的表达水平。miRNA在深静脉血栓形成的发生、发展及治疗中展现出潜在的应用价值。深静脉血栓形成(DVT)是指深静脉腔内的血液异常凝结,阻塞静脉管腔,导致静脉回流障碍,多见于下肢,血栓脱落入肺可引起死亡。本文综述了近年来关于miRNA在DVT中的多元化作用机制。鉴于通过针对性的治疗手段调节miRNA的表达可能对DVT的康复具有促进作用,本文还详细讨论了miRNA在DVT临床诊断和治疗中的潜在应用,旨在为DVT领域的临床和基础研究提供有价值的参考。
Research progress on microRNAs in deep vein thrombosis
MicroRNAs(miRNAs)comprise a class of endogenous RNA molecules with a typical length of 19~25 nucleotides.They regulate gene expression levels by identifying homologous sequences and intervening in transcription,translation,or epigenetic processes.miRNAs have potential applications in relation to the pathogenesis,progression,and treatment of deep vein thrombosis(DVT).DVT refers to the abnormal coagulation of blood within the lumen of the deep veins,blocking the venous lumen and obstructing the venous return,especially in the lower limbs.Furthermore,detachment of the thrombus and entry into the lungs can lead to death.This article comprehensively reviews recent research findings regarding the diverse mechanisms of action of miRNAs in relation to DVT.Given that the regulation of miRNA expression using targeted therapeutic approaches may promote the recovery of DVT,this article also discusses the potential applications of miRNAs for the clinical diagnosis and treatment of DVT,and aims to provide valuable references and insights for future clinical and basic research in the field of DVT.

deep vein thrombosismiRNAmechanism of actionbiomarkertreatment

李磊、袁启东、彭喜涛、朱瑾、彭俊才、何长海、付利晴

展开 >

河南中医药大学第一附属医院周围血管科,郑州 450000

河南中医药大学第一临床医学院,郑州 450000

河南省直第三人民医院,郑州 450000

深静脉血栓形成 miRNA 作用机制 生物标志物 治疗

2024

中国比较医学杂志
中国实验动物学会,中国医学科学院医学实验动物研究所

中国比较医学杂志

CSTPCD北大核心
影响因子:0.473
ISSN:1671-7856
年,卷(期):2024.34(11)